housing Grant Search

The following government grants in the FederalGrants.com database contain the term housing in the listing.

Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.

 

 

 

 
 
 Grant TitleCFDAFunding Number
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) 93.113, 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.307, 93.361, 93.399, 93.853, 93.855, 93.856, 93.865, 93.866 PAR-18-017
NIH Research Project Grant (Parent R01 Clinical Trial Required) 93.113, 93.172, 93.213, 93.233, 93.273, 93.279, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.859, 93.866 PA-18-345
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) 93.395 PA-18-014
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) 93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.307, 93.361, 93.399, 93.837, 93.838, 93.839, 93.853, 93.855, 93.856, 93.865, 93.866 PAR-18-007
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) 93.394, 93.866 PA-18-005
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) 93.395 PA-18-004
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) 93.279 PA-18-060
Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional) 93.865 PA-18-046
Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional) 93.865 PA-18-045
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) 93.394, 93.866 PA-18-015
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) 93.393, 93.399 PAR-18-006
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional) 93.865 PA-18-043
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional) 93.865 PA-18-038
Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional) 93.865 PA-18-033
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) 93.393, 93.399 PAR-18-016
2018 VA GPD Per Diem Only NOFA 64.024 2018-PDO-NOFA
NCI Research Specialist (Core-based Scientist) Award (R50) 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 PAR-18-342
NCI Research Specialist (Laboratory-based Scientist) Award (R50) 93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 PAR-18-341
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) 93.173 PA-18-288
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) 93.213 PAR-18-118
Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) 93.213 PAR-18-115
Prescription Drug Abuse (R01 Clinical Trial Optional) 93.279 PA-18-058
Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01 Clinical Trial Optional) 93.279 PA-18-056
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional) 93.233, 93.273, 93.321, 93.361, 93.393, 93.399, 93.837, 93.838, 93.839, 93.847, 93.865 PAR-18-112
Studies at Periviable Gestation (R21 Clinical Trial Optional) 93.865 PA-18-097
Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional) 93.865 PA-18-092
Prescription Drug Abuse (R21 Clinical Trial Optional) 93.279 PA-18-076
Studies at Periviable Gestation (R01 Clinical Trial Optional) 93.865 PA-18-036
Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional) 93.173 PA-18-287
Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required) 93.213 PAR-18-114
Studies at Periviable Gestation (R03 Clinical Trial Optional) 93.865 PA-18-053
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) 93.393, 93.837 PA-18-013
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) 93.393, 93.837 PA-18-003
Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional) 93.399 PA-18-002
Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21 Clinical Trial Optional) 93.279 PA-18-075
Behavioral and Integrative Treatment Development Program (R03 Clinical Trial Optional) 93.273, 93.279 PA-18-074
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) 93.273, 93.279 PA-18-073
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) 93.273, 93.279 PA-18-055
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional 93.173, 93.233, 93.242, 93.286, 93.399, 93.837, 93.838, 93.839, 93.840 PA-18-339
Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) (Clinical Trials Not Allowed) 93.233, 93.242, 93.837, 93.838, 93.839, 93.840 PA-18-338
Search Results 7041-7080 of 17601
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next]

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com